Guest column Houston primed for opportunity within the tech inversion caused by the pandemic Tony Loyd
fresh funding Houston biotech startup secures $10M seed round to propel cancer-fighting therapy from bench to bedside
money moves Houston firm scores 2 grants to support testing treatment for addiction, neurodegenerative diseases
